The effect of a diabetes-specific cognitive behavioral treatment program (diamos) for patients with diabetes and subclinical depression: Results of a randomized controlled trial

Diabetes Care

Volumn 38, Issue 4, 2015, Pages 551-560

  Hermanns, Norbert ^a,b,c   Schmitt, Andreas ^a   Gahr, Annika ^a   Herder, Christian ^d,e   Nowotny, Bettina ^d   Roden, Michael ^d,e   Ohmann, Christian ^d   Kruse, Johannes ^f   Haak, Thomas ^a,b   Kulzer, Bernhard ^a,b,c  

^a Res Inst Diabet Acad Mergentheim   (Germany)

^b Diabetes Center Mergentheim   (Germany)

^c UNIVERSITY OF BAMBERG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ADULT; ARTICLE; COGNITIVE THERAPY; DEPRESSION; DIABETES EDUCATION; DIABETES MOTIVATION STRENGTHENING; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SEX DIFFERENCE; TREATMENT DURATION; ASYMPTOMATIC DISEASE; COMORBIDITY; COMPLICATION; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MOTIVATION; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ASYMPTOMATIC DISEASES; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; SELF CARE; TREATMENT OUTCOME;

EID: 84938201004     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1416     Document Type: Article

References (40)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001;24:1069-1078.
2. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med 2008;25:1096-1101.
3. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care 1999;22:448-452.
4. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: A population study. Diabetes Care 2004;27:1066- 1070.
5. Saatci E, Tahmiscioglu G, Bozdemir N, Akpinar E, Ozcan S, Kurdak H. The well-being and treatment satisfaction of diabetic patients in primary care. Health Qual Life Outcomes 2010;8:67.
6. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetesspecific emotional problems and standard clinical assessment. Diabetologia 2006;49:469-477.
7. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale. Diabetes Care 2005;28:626-631.
8. Bassett J, Adelman A, Gabbay R, A~nel-Tiangco RM. Relationship between depression and treatment satisfaction among patients with type 2 diabetes. J Diabetes Metab 2012;3:1000210.
9. Gonzalez JS, PeyrotM, McCarl LA, et al. Depression and diabetes treatment nonadherence: Ameta-analysis. Diabetes Care 2008;31:2398-2403.
10. Schmitt A, Reimer A, Kulzer B, Haak T, Gahr A, Hermanns N. Assessment of diabetes acceptance can help identify patients with ineffectivediabetes self-care and poor diabetes control. Diabet Med 2014;31:1446-1451.
11. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003;26:2822-2828.
12. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004;27:421-428.
13. Sullivan MD, O'Connor P, Feeney P, et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 2012;35:1708-1715.
14. Katon W, Fan MY, Unutzer J, Taylor J, Pincus H, Schoenbaum M. Depression and diabetes: A potentially lethal combination. J Gen Intern Med 2008;23:1571-1575.
15. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL- 1, and IL-6: A meta-analysis. Psychosom Med 2009;71:171-186.
16. Laake JP, Stahl D, Amiel SA, et al. The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care 2014;37:2186-2192.
17. Hood KK, Lawrence JM, Anderson A, et al.; SEARCH for Diabetes in Youth Study Group. Metabolic and inflammatory links todepression in youth with diabetes. Diabetes Care 2012;35:2443-2446.
18. Herder C, Carstensen M, Ouwens DM. Antiinflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 2013;15(Suppl. 3):39-50.
19. American Diabetes Association. Standards of medical care in diabetesd2013. Diabetes Care 2013;36(Suppl. 1):S11-S66.
20. National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: National Clinical Practice Guideline No. 91 [article online], 2009. Available from www.nice.org.uk/CG91. Accessed 13 June 2011.
21. Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have webeen missing something important? Diabetes Care 2011;34:236-239.
22. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabet Med 2014;31:764-772.
23. Kacerovsky-Bielesz G, Lienhardt S, Hagenhofer M, et al. Sex-related psychological effects on metabolic control in type 2 diabetes mellitus. Diabetologia 2009;52:781-788.
24. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 129:613-621.
25. Hautzinger M, Bailer J. Allgemeine Depressions- Skala. Gottingen, Hogrefe, 1993.
26. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
27. Welch GW, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care 1997; 20:760-766.
28. Toobert DJ, Hampson SE, Glasgow RE. The Summary of Diabetes Self-Care Activities Measure: results from 7 studies and a revised scale. Diabetes Care 2000;23:943-950.
29. Greiner W, Claes C. Der EQ-5D der EuroQoLGruppe. In Gesundheitsokonomische Evaluationen. Graf von der Schulenburg J-M, Schoffski O, Eds. Heidelberg, Springer, 2007, p. 403-414.
30. Gregg JA, Callaghan GM, Hayes SC, Glenn- Lawson JL. Improving diabetes self-management through acceptance, mindfulness, and values: A randomized controlled trial. J Consult Clin Psychol 2007;75:336-343.
31. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In Handbook of Psychology and Diabetes. Bradley C, Ed. Amsterdam, Harwood Academic Publishers, 1994, p. 111-132.
32. Judd LL, Schettler PJ, Akiskal HS. The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am 2002;25:685-698.
33. Unutzer J, Schoenbaum M, Katon WJ, et al. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants. J Am Geriatr Soc 2009;57:506-510.
34. Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care 2012; 35:259-264.
35. Fisher L, Hessler D, Glasgow RE, et al. REDEEM: A pragmatic trial to reduce diabetes distress. Diabetes Care 2013;36:2551-2558.
36. van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: A systematic review and meta-analysis. Gen Hosp Psychiatry 2010;32:380-395.
37. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev 2012;12:CD008381.
38. Herder C, Bongaerts BW, Rathmann W, et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care 2013;36:3663-3670.
39. Hermanns N, Kulzer B, Ehrmann D, Bergis- Jurgan N, Haak T. The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: results of a randomized trial. Diabetes Res Clin Pract 2013;102:149- 157.
40. Hermanns N, Kulzer B, Maier B, Mahr M, Haak T. The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes. Patient Educ Couns 2012;86:226-232.